CS-917
Phase 2- Indications
- Type 2 diabetes
Company intelligence / Profile preview
Metabasis Therapeutics
San Diego, California, United Statessec.gov ↗
- Ownership
- Private
- Development stage
- Phase 2
01
Overview
Metabasis Therapeutics developed a broad pipeline targeting metabolic and liver diseases using proprietary technologies such as HepDirect® for targeted drug delivery to the liver. Its lead programs included a TR Beta agonist for hyperlipidemia, PTP‑1B inhibitors for diabetes, and adenosine regulating agents. Several candidates reached clinical trials; one program licensed out was in Phase III at the time of acquisition.
- Therapeutic areas
- Metabolic DisordersCardiovascularGastroenterology
- Modalities
- Small moleculesProdrugs (notably via HepDirect® technology)NuMimetic™ technology-based compounds
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
Request access →03
Partnerships
Roche partnership acquired by Ligand through this dealPeriCor Therapeutics sublicensed rights from MetabasisMerck & Co. (via PeriCor Therapeutics)
Beyond the preview
Go deeper on Metabasis Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Metabasis Therapeutics.